Saluda Medical Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Net Income	-162.61	-149.3	-97.83	-92.16
Depreciation & Amortization	2.69	2.61	2.63	2.31
Other Amortization	21.17	20.61	-	-
Loss (Gain) From Sale of Assets	0.03	0.03	0.06	0.07
Loss (Gain) From Sale of Investments	1.47	7.15	-	-
Stock-Based Compensation	17.59	14.03	3.74	6.26
Provision & Write-off of Bad Debts	0.62	0.17	0.37	0.56
Other Operating Activities	0.7	1.58	4.37	4.89
Change in Accounts Receivable	-3.29	-1.68	-5.74	-3.94
Change in Inventory	-5.44	-17.58	-6.65	-9.15
Change in Accounts Payable	4.33	4.33	6.68	7.4
Change in Unearned Revenue	0.02	0.55	-	-
Change in Income Taxes	0.26	0.35	-0.13	0.43
Change in Other Net Operating Assets	1.64	-1.08	-0.83	-2.31
Operating Cash Flow	-120.84	-118.24	-93.32	-85.66
Capital Expenditures	-1.24	-1.27	-1.08	-2.37
Investing Cash Flow	-1.24	-1.27	-1.08	-2.37
Long-Term Debt Issued	-	172.83	-	-
Long-Term Debt Repaid	-	-71.45	-	-
Net Debt Issued (Repaid)	101.38	101.38	-	-
Issuance of Common Stock	167.33	0.09	0.03	0.12
Other Financing Activities	-13.26	-3.54	-0.31	-
Financing Cash Flow	255.45	97.94	-0.28	143.83
Foreign Exchange Rate Adjustments	3.69	4.28	-0.26	-0.69
Net Cash Flow	137.07	-17.29	-94.95	55.11
Free Cash Flow	-122.08	-119.51	-94.4	-88.03
Free Cash Flow Margin	-160.49%	-169.87%	-182.66%	-395.93%
Free Cash Flow Per Share	-3.17	-36.75	-29.07	-27.13
Cash Interest Paid	26.45	26.45	-	-
Cash Income Tax Paid	0.1	0.1	0.86	0.19
Levered Free Cash Flow	-	-67.53	-71.68	-
Unlevered Free Cash Flow	-	-71.12	-68.56	-
Change in Working Capital	-2.49	-15.11	-6.66	-7.58

Source: S&P Global Market Intelligence. Standard template. Financial Sources.